The U.S. has one of the highest maternal mortality rates in the developed world, with women of color especially at risk. Dr. Robyn R. Jones, Senior Medical Director at Johnson & Johnson, is determined to change that and find ways to address this urgent crisis.
Most people obtain a medication when their doctors write a prescription. That prescribed medication has been studied, evaluated and approved by a national regulatory authority, such as the U.S. Food and Drug Administration (FDA). However, for patients with very serious and/or life-threatening conditions who have exhausted all currently available treatment options and are not eligible to participate in a clinical trial, compassionate use may be an option.
With health insurance enrollment season in full swing, you may be researching which plan to get—and signing those data disclosure forms. But have you ever wondered how some of that info is used once you sign on the dotted line?
For Baby Safety Month, we sat down with the company's Head of Pediatric Drug Development to learn about its industry-leading Child Health Innovation Leadership Department.
A serious tumble can make any parent panic. Edwin Kuffner, M.D., Chief Medical Officer for Johnson & Johnson Consumer Inc., shares his expert advice for how to handle a potential concussion.
With the summer season in full swing, we asked Edwin Kuffner, M.D., Chief Medical Officer for Johnson & Johnson Consumer Inc., to share his expert advice for soothing red skin—and, better yet, keeping it protected from burns.
Established in 2013, Johnson & Johnson’s Office of the Chief Medical Officer (OCMO) is a global team encompassing safety colleagues from across all sectors of Johnson & Johnson. Functionally independent from commercial interests, we focus entirely on the safety of all products across the Johnson & Johnson Family of Companies. Our approach is reinforced by a cutting-edge single medical safety standard to which all of our products are held.
The company's mission is to care for the world—one person at a time. Just ask Chief Medical Officer Joanne Waldstreicher, M.D., who's been leading the charge to improve the process by which very sick patients may apply for access to investigational medications.